Literature DB >> 33012502

Dual adjunct therapy with dexamethasone and dexmedetomidine in transversus abdominis plane blocks reduces postoperative opioid use in colorectal surgery.

Brandon C Chapman1, Brian Shepherd2, Richard Moore3, Daniel J Stanley3, Eric C Nelson3.   

Abstract

BACKGROUND: The objective of this study is to determine if the addition of dexmedetomidine to dexamethasone in transversus abdominis plane (TAP) blocks lowers postoperative opioid use following colorectal surgery.
METHODS: Retrospective review of patients undergoing minimally invasive colorectal surgery and perioperative TAP block with either 1) local anesthetic and dexamethasone or 2) local anesthetic, dexamethasone, and dexmedetomidine. Post-operative opioid use was converted to morphine milligram equivalents (MME).
RESULTS: 55 patients were identified: 38 (69%) receiving dexamethasone only and 17 (31%) receiving dexamethasone and dexmedetomidine. The dexamethasone and dexmedetomidine group had significantly lower median MME use at 12-h (2 vs. 13 mg), 24-h (4 vs. 28 mg), 36-h (8 vs. 38 mg), and 48-h (17 vs. 53 mg) (all p < 0.05). There was no difference at 72-h.
CONCLUSION: Perioperative TAP blocks with dexamethasone and dexmedetomidine following colorectal surgery results in significantly less postoperative opioid use up to 48 h after surgery.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Abdominal surgery; Colorectal surgery; Opioid(s); Pain; TAP block

Mesh:

Substances:

Year:  2020        PMID: 33012502     DOI: 10.1016/j.amjsurg.2020.09.027

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  1 in total

1.  Superior Block Length and Reduced Opioid Use with Dexmedetomidine and Dexamethasone regional block versus plain Ropivacaine: a retrospective trial.

Authors:  Amnon A Berger; Zuby Syed; Lianne Ryan; Christopher Lee; Jamal Hasoon; Ivan Urits; Omar Viswanath; Elyse M Cornett; Alan D Kaye; Jonathan P Eskander
Journal:  Orthop Rev (Pavia)       Date:  2022-04-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.